BGI Excited to be at AACR 2019!

BGI Excited to be at AACR 2019!

We’re excited to be in Atlanta for AACR. Come say hi at booth #1643 and learn how we can support your cancer research with our world-class sequencing services. We will introduce a new Hereditary Cancer Panel to support your biomarker discovery or cancer research will and present a workshop on Biomarker-driven precision medicine. Scroll down for the details…

Be Inspired! At our Spotlight Theater SeminarBGI at PAG lightbulb

Attend our educational seminar to be inspired by leaders in cancer genomics to learn about the application of NGS tools in precision cancer treatment.


Case Studies of Biomarker-Assisted Patient Stratification for Oncology Precision Medicine

Sunday, March 31, 2019
3:30-4:30 PM
Spotlight Theater C on the exhibit floor

Biomarker testing and companion diagnostic development for precision medicine
Yu-Zhen Liu, Ph.D.
Global Diagnostic Expert, Precision Medicine & Genomics, Global R&D, AstraZeneca

Refining the Precision Medicine for Pancreatic Cancer
Lei Zheng, MD, Ph.D.
Co-Director, the “Precision Medicine Center of Excellence” for Pancreatic Cancer, Johns Hopkins University School of Medicine


Introducing Hereditary Cancer Panel

Our Hereditary Cancer Panel offers flexible solutions for applications including biomarker discovery, patient enrollment, risk evaluation and screening. Flexibility in reporting options for up to 115 genes, based on BGI’s comprehensive proprietary database, allow you to scale a solution to fit your needs and budget.

Hereditary Cancer Panel samples are processed in our CAP accredited and CLIA certified service laboratory

Meet Our Scientists

Following a rich history of contribution to Genomic Science, BGI scientists will be presenting a variety of posters during this AACR meeting:

Non-invasive detection of aberrant DNA methylation in colorectal cancer by multiplex methylation specific PCR

[Lili Ye, Chunting Zheng] et al.  Learn More

Development of a cfDNA based trans-omics approach for early cancer detection

[Yuying Wang] et al.  Learn More

Comprehensive analysis of immune evasion in breast cancer by single-cell RNA-seq

[Jianhua Yin, Hanlin Zhou] et al.  Learn More

Analysis of the tumor microenvironment in seven cancer types by single-cell RNA-seq

[Michael Dean] et al.  Learn More

Intratumor heterogeneity of non-small-cell lung cancer with EGFR

[Sitan Qiao, Xin Zhao, Xinlan Zhou] et al.  Learn More

High-throughput unbiased microwell-based single-cell CNV detection reveals tumor clonal subtypes in hepatocellular carcinoma

[Liang Wu, Yuzhou Wang] et al.  Learn More

EPIC: MHC-I epitope prediction integrating mass spectrometry derived motifs and tissue-specific expression profiles

[Weipeng Hu] et al.  Learn More
Share with your community
Quick Contact